Ausgabe 2/2020
Inhalt (10 Artikel)
Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma
Kyle Wierzbicki, Karthik Ravi, Andrea Franson, Amy Bruzek, Evan Cantor, Micah Harris, Morgan J. Homan, Bernard L. Marini, Abed Rahman Kawakibi, Ramya Ravindran, Rodrigo Teodoro, Viveka Nand Yadav, Carl Koschmann
Antibody-Drug Conjugates in Urothelial Carcinomas
Michal Sarfaty, Jonathan E. Rosenberg
Trimodality Therapy for Muscle-Invasive Bladder Cancer: Recent Advances and Unanswered Questions
Di Maria Jiang, Peter Chung, Girish S. Kulkarni, Srikala S. Sridhar
Pregnancy and Cancer: the INCIP Project
Charlotte Maggen, Vera E. R. A. Wolters, Elyce Cardonick, Monica Fumagalli, Michael J. Halaska, Christianne A. R. Lok, Jorine de Haan, Katrien Van Tornout, Kristel Van Calsteren, Frédéric Amant
Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?
Christine De Bruyn, Thaïs Baert, Thierry Van den Bosch, An Coosemans
Immunotherapy for the Treatment of Acute Lymphoblastic Leukemia
Valentin Barsan, Sneha Ramakrishna, Kara L. Davis
Revolution of Chronic Lymphocytic Leukemia Therapy: the Chemo-Free Treatment Paradigm
Annika Scheffold, Stephan Stilgenbauer
Oligometastatic Breast Cancer: Is This a Curable Entity? A Contemporary Review of the Literature
Igor Makhlin, Kevin Fox
Pharmacogenomics of Pain Management: The Impact of Specific Biological Polymorphisms on Drugs and Metabolism
Elyse M. Cornett, Michelle A. Carroll Turpin, Allison Pinner, Pankaj Thakur, Tamizh Selvan Gnana Sekaran, Harish Siddaiah, Jasmine Rivas, Anna Yates, G. Jason Huang, Anitha Senthil, Narjeet Khurmi, Jenna L. Miller, Cain W. Stark, Richard D. Urman, Alan David Kaye
Dashing Decades of Defeat: Long Anticipated Advances in the First-line Treatment of Extensive-Stage Small Cell Lung Cancer
Samantha A. Armstrong, Stephen V. Liu